A scalable portfolio approach linking independent medical practices with institutional resources, patient capital, and reliable healthcare data.
Made in USA Inc. (OTCMKTS:USDW)
Our view was that the gap wasn’t the physicians or the funding—it was the connective tissue in between.”— Austin Reiser, Zenyte Holdings Corp.
Zenyte Holdings Corp. (“Zenyte”) and Made in USA Inc. (OTC: USDW) have announced a strategic collaboration aimed at establishing a fresh public-market route for independent healthcare providers—enabling physicians to share in the value generated by institutional reach without sacrificing the clinical and operational autonomy that drove their practices’ success.
For independent doctors and practice owners, this framework is intended to deliver something historically hard to achieve: the chance to stay autonomous while becoming part of a much larger entity. Zenyte integrates technology, financial structuring, audit readiness, transaction frameworks, and portfolio assembly to assist independent practices in preparing for, aligning with, and benefiting from institutional and capital-market prospects.
For patient investors, the same platform is meant to offer access to specialized portfolios constructed from real, operating healthcare enterprises with proven revenue streams. Zenyte has already confirmed over $100 million in practice collections directly from supporting financial documentation, while cultivating ties with a considerably wider network of independent practices that management believes can support the creation of several healthcare portfolios over time.
The broader potential lies in the model’s design for replication. Instead of putting together a single healthcare consolidation, Zenyte is developing an adaptable portfolio architecture through which qualifying independent entities can be grouped into specialized portfolios centered on various market niches, medical specialties, strategic aims, and enduring partnerships. Each portfolio can be built, financially organized, and readied for institutional involvement—and the same framework can then be applied to the next portfolio. A single portfolio is a deal. A repeatable portfolio system is infrastructure.
That repeatability opens up a distinct opportunity for capital. Portfolios built from established, operational healthcare businesses can serve as platforms for strategic initiatives, long-term financial alliances, technology rollouts, acquisitions, supplementary services, and investments that would be challenging for any single independent practice to pursue alone. Zenyte’s core belief is that capital ought to reinforce physician leadership, not supplant it: doctors keep doing what they excel at, while the portfolio provides the scale and financial backbone through which long-term partners can share in the value those enterprises create.
The partnership with USDW also opens a route into what the companies view as potentially one of healthcare’s most valuable long-term resources: reliable data. USDW has built infrastructure around data origin, verification, certification, and permissioned data systems, including DataWallet™ technology, ERP and IoT capabilities, and blockchain-based verification infrastructure. USDW has also publicly disclosed a proposed venture in the life sciences business segment—a planned healthcare and life-sciences initiative focused on secure, verifiable, and permissioned data ecosystems. As the Zenyte portfolio ecosystem grows, the Company anticipates evaluating how trusted-data infrastructure can benefit participating practices, clinical and research uses, responsible AI, and a longer-term future where patients have greater transparency and control over how their healthcare data is permissioned and utilized.
“We didn’t begin by asking how to consolidate healthcare,” said Austin Reiser of Zenyte Holdings. “We began by asking why independent physicians, long-term capital, and the technologies shaping healthcare’s future have been so hard to link without undermining physician autonomy. We believe the missing piece is the infrastructure between them. Build that infrastructure correctly, and a doctor does not have to pick between independence and scale. Investors do not have to pick between established operating businesses and long-term opportunity. And healthcare can start constructing a financial and data ecosystem around the people it was meant to serve all along.”
About Zenyte Holdings Corp.
Zenyte Holdings Corp. creates institutional infrastructure for independent businesses by merging technology, financial organization, systems integration, due diligence preparation, transaction design, and portfolio development into a cohesive framework.
Zenyte calls this process Portfolio Manufacturing™: integrating independent operating businesses, financial data, technology, professional advisors, strategic partners, and capital-market avenues into purpose-built institutional portfolios. The model is intended to let independent business owners share in the opportunities created by greater scale while preserving the leadership, identity, and operational strengths that generated the underlying value.
About Made in USA Inc.
Made in USA Inc. (OTC: USDW) is a publicly traded technology firm developing infrastructure focused on data provenance, certification, verification, and digital trust. The company’s disclosed technology infrastructure includes AI-enabled verification tools, blockchain frameworks, ERP systems with IoT integration, and modular DataWallet™ technology.
USDW has also announced that the Company is pursuing a proposed initiative designed to extend its data-wallet and certification technologies into healthcare and life sciences via secure, verifiable, and permissioned data ecosystems. Within the Zenyte relationship, USDW is intended to offer a public-market pathway while creating opportunities to assess complementary technologies, strategic ventures, and other portfolio-level initiatives.
